2022 Disease Hospital Radiation 
Imaging Technology
APRIL 26, 2023
The guideline is published in Practical Radiation Oncology. The guideline emphasizes the need for a multidisciplinary team approach to guide treatment decisions for oligometastatic disease, a description for cancer that reaches a state in which the patient has a small number of metastases in addition to a primary tumor.
Imaging Technology
DECEMBER 20, 2023
NM-101 is a cloud-based analysis platform that is able to seamlessly integrate into existing workflows at hospitals and imaging centers. The device allows doctors to send neuromelanin MRI images to Terran directly through the hospital picture archiving and communication system (PACS) and receive a full report back in under an hour.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
MARCH 26, 2024
Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.
Imaging Technology
NOVEMBER 22, 2023
Bringing lung cancer screening to the Buffalo community in New York state In 2022, Philips teamed up with Roswell Park Comprehensive Cancer Center (Buffalo, New York, U.S.) We needed to move screening outside of institutions and hospitals and offer it in the neighborhood where people will get used to seeing it.”
Imaging Technology
OCTOBER 5, 2023
Teams reported new findings about radiation-induced secondary cancers, a new guidance system for radiation therapy, and the consequences of insurance denials, among other topics. Haupt Chair in Radiation Oncology, was honored with ASTRO’s Gold Medal Award. These are some of the highlights.
AuntMinnie
APRIL 4, 2024
Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. However, few freestanding theranostics centers exist today. Hope added. Morris continued in the JNM.
AuntMinnie
JUNE 20, 2024
Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.
Expert insights. Personalized for you.
77 
Let's personalize your content